Last Updated:

COVID-19: Cipla Launches RT-PCR Test Kit 'ViraGen' In India Partnership With Ubio Biotech

Cipla will commence supply of the COVID-19 virus detection kit from May 25, 2021.

Cipla

Image: Cipla


New Delhi, May 20 (PTI) Drug major Cipla on Thursday announced the commercialisation of its RT-PCR test kit 'ViraGen' for COVID-19 in India, in partnership with Ubio Biotechnology Systems. 

"This launch will help address the current testing services and capacity issues while reaffirming the company's ongoing expansion in the diagnostic space," Cipla said in a regulatory filing.

Cipla will launch ViraGen test kit in the country in partnership with Ubio Biotechnology Systems, the company stated.

The company will commence supply of the COVID-19 virus detection kit from May 25, 2021.

Umang Vohra, MD and Global CEO, Cipla, said, Cipla has been working relentlessly to ensure accessibility to treatments in this fight against COVID-19. Guided by our core purpose of 'Caring for Life', this partnership will enable us to reach out to more people across the country at a crucial time like now.

ViraGen is Cipla's third offering in the COVID-19 testing segment. 

First Published: